| || Freemont, California|
|contact, function|| ||department|| ||email|| ||direct dial|
Company profileVerseon Corporation is a technology-based pharmaceutical company that pairs a proprietary, computational drug discovery platform with a comprehensive chemistry and biology workflow to develop novel therapeutics that are unlikely to be found using conventional methods. Verseon has four active drug programs in the areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. The anticoagulation program is scheduled to enter phase I clinical trials in 2018.